title: Pharmacovigilance practices for better healthcare delivery: knowledge and attitude study in the national malaria control programme of India.
abstract: Objective. With large scale rollout of artemisinin based therapy in the National Malaria Control Programme of India, a risk management plan is needed. This depends on adverse drug reaction (ADR) reporting by the healthcare professionals (HCPs). For the programme to be successful, an understanding of the mindset of HCPs is critical. Hence, the present study was designed to assess and compare the ADR reporting beliefs of HCPs involved in the National Malaria Control Programme of India. Methods. A cross-sectional survey was conducted amongst the HCPs who manage malaria up to the district level in India. A 5-point Likert scale-based questionnaire was developed as a study tool. Results. A total of 154 HCPs participated in the study (age: 42.4 ± 10.1 years with 33.8% being females). About 61% felt that only medically qualified HCPs are responsible for ADR reporting. Likeliness to report in future was mentioned by 45% HCPs. The knowledge score was relatively lower for life science graduates (P = 0.09). Knowledge correlated positively with attitude (r (2) = 0.114; P < 0.0001). Conclusion. Based on the caveats identified, a specific and targeted in-service education with hands-on training on ADR monitoring and reporting needs to be designed to boost real time pharmacovigilance in India.
authors.affiliation: Department of Pharmacology, All India Institute of Medical Sciences, New Delhi 110029, India.
authors.forename: Pooja
authors.initials: P
authors.lastname: Gupta
authors.affiliation: National Institute of Malaria Research, Indian Council of Medical Research, New Delhi 110077, India.
authors.forename: Anupkumar R
authors.initials: AR
authors.lastname: Anvikar
authors.affiliation: National Institute of Malaria Research, Indian Council of Medical Research, New Delhi 110077, India.
authors.forename: Neena
authors.initials: N
authors.lastname: Valecha
authors.affiliation: Department of Pharmacology, All India Institute of Medical Sciences, New Delhi 110029, India ; Pharmacovigilance Programme of India, India.
authors.forename: Yogendra K
authors.initials: YK
authors.lastname: Gupta